RPG LifeScience.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE105J01010
  • NSEID: RPGLIFE
  • BSEID: 532983
INR
2,386.10
65.6 (2.83%)
BSENSE

May 06

BSE+NSE Vol: 26.13 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Mar'25
Dec'24
Net Sales
176.89
180.03
181.68
143.09
172.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
176.89
180.03
181.68
143.09
172.71
Raw Material Cost
36.43
34.79
32.72
26.89
30.19
Purchase of Finished goods
22.63
43.63
38.78
21.22
22.70
(Increase) / Decrease In Stocks
1.53
-13.52
-4.92
0.61
3.22
Employee Cost
36.30
35.32
36.16
31.60
28.71
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
47.17
40.05
39.91
37.28
38.73
Total Expenditure (Excl Depreciation)
144.06
140.27
142.65
117.60
123.55
Operating Profit (PBDIT) excl Other Income
32.83
39.76
39.03
25.49
49.16
Other Income
12.40
3.41
4.54
5.06
3.31
Operating Profit (PBDIT)
45.23
43.17
43.57
30.55
52.47
Interest
0.39
0.25
0.12
0.18
0.12
Exceptional Items
1.10
-8.42
11.22
109.90
0.00
Gross Profit (PBDT)
45.94
34.50
54.67
140.27
52.35
Depreciation
5.74
5.38
5.22
5.37
5.46
Profit Before Tax
40.20
29.12
49.45
134.90
46.89
Tax
10.30
6.99
12.60
17.55
11.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
29.90
22.13
36.85
117.35
34.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
29.90
22.13
36.85
117.35
34.93
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
29.90
22.13
36.85
117.35
34.93
Equity Capital
13.23
13.23
13.23
13.23
13.23
Face Value
8.0
8.0
8.0
8.0
8.0
Reserves
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
18.08
13.38
22.28
70.96
21.12
Diluted Earnings per share
18.08
13.38
22.28
70.96
21.12
Operating Profit Margin (Excl OI)
18.56%
22.09%
21.48%
17.81%
28.46%
Gross Profit Margin
25.97%
19.16%
30.09%
98.03%
30.31%
PAT Margin
16.9%
12.29%
20.28%
82.01%
20.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -1.74% vs -0.91% in Dec 2025

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 35.11% vs -39.95% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -17.33% vs 1.87% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 56.00% vs 108.33% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of RPG LifeScience. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
176.89
0
176.89
Other Operating Income
0.00
0.00
0.00
Total Operating income
176.89
0
176.89
Raw Material Cost
36.43
0
36.43
Purchase of Finished goods
22.63
0
22.63
(Increase) / Decrease In Stocks
1.53
0
1.53
Employee Cost
36.30
0
36.30
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
47.17
0.00
47.17
Total Expenditure (Excl Depreciation)
144.06
0
144.06
Operating Profit (PBDIT) excl Other Income
32.83
0.00
32.83
Other Income
12.40
0
12.40
Operating Profit (PBDIT)
45.23
0
45.23
Interest
0.39
0
0.39
Exceptional Items
1.10
0
1.10
Gross Profit (PBDT)
45.94
0
45.94
Depreciation
5.74
0
5.74
Profit Before Tax
40.20
0
40.20
Tax
10.30
0
10.30
Provisions and contingencies
0.00
0
0.00
Profit After Tax
29.90
0
29.90
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
29.90
0
29.90
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
29.90
0
29.90
Equity Capital
13.23
0
13.23
Face Value
8.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
18.08
0
18.08
Diluted Earnings per share
18.08
0
18.08
Operating Profit Margin (Excl OI)
18.56%
0%
0.00
18.56%
Gross Profit Margin
25.97%
0%
0.00
25.97%
PAT Margin
16.90%
0%
0.00
16.90%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 176.89 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -1.74% vs -0.91% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 23.62% vs 12.68% in Mar 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 29.90 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 35.11% vs -39.95% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -74.52% vs 786.33% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.87 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -17.33% vs 1.87% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 28.95% vs 23.02% in Mar 2025

Quarterly - Interest
Interest 0.39 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 56.00% vs 108.33% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 116.67% vs 28.57% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.58%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025